Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penetration of Ceftaroline Into Cerebrospinal Fluid
NCT02806882Phase 1Completed
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Apr 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ceftaroline fosamil in meningitis and ventriculitis, sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoints: Ceftaroline serum concentration at 24 hours and Ceftaroline cerebrospinal fluid concentration at 24 hours. Started Apr 2015; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
meningitisventriculitis
Beyond the preview
Go deeper on NCT02806882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806882.